Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Bernd Schnabl

Photo of Bernd Schnabl
Title(s)Professor, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Overview 

    Collapse Research 
    Collapse research activities and funding
    San Diego Digestive Diseases Research Center
    NIH P30DK120515Jul 1, 2019 - Apr 30, 2024
    Role: Principal Investigator
    The role of Enterococcus faecalis in alcoholic liver disease
    VA I01BX004594Oct 1, 2018 - Sep 30, 2022
    Role: Principal Investigator
    Microbiome as therapeutic target in alcoholic hepatitis
    NIH/NIAAA U01AA026939Sep 22, 2018 - Jun 30, 2023
    Role: Principal Investigator
    The Role of the Intestinal Mycobiome in Alcoholic Liver Disease
    NIH/NIAAA R01AA024726Apr 10, 2017 - Mar 31, 2022
    Role: Principal Investigator
    The Role of the Intestinal Mycobiome in Alcoholic Liver Disease
    NIH/NIAAA U01AA024726Apr 10, 2017 - Mar 31, 2022
    Role: Principal Investigator
    The Commensal Microflora Suppresses Liver Fibrosis
    VA I01BX002213Oct 1, 2014 - Sep 30, 2018
    Role: Principal Investigator
    Microbiome as Therapeutic Target in Alcoholic Hepatitis
    NIH U01AA021856Jun 1, 2013 - May 31, 2019
    Role: Principal Investigator
    Microbiome and intestinal innate immune response in alcoholic liver disease
    NIH/NIAAA R01AA020703Sep 25, 2011 - Jun 30, 2021
    Role: Principal Investigator
    Blocking toll-like receptor 4 signaling as therapy in hepatic fibrosis
    NIH/NIDDK K08DK081830Sep 30, 2009 - Jun 30, 2014
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. mAChR4 suppresses liver disease via GAP-induced antimicrobial immunity. Nature. 2025 Aug 20. Llorente C, Raya Tonetti F, Bruellman R, Brea R, Pell N, Hartmann P, Maccioni L, Han H, Cabré N, Liu J, Eguileor A, Fondevila MF, Meijnikman AS, Hsu CL, Alghafri A, Zhou R, Gao B, Duan Y, Zhang P, Febbraio MA, Taniguchi K, Newberry RD, Fouts DE, Brenner DA, Stärkel P, Karin M, Schnabl B. PMID: 40836099.
      View in: PubMed   Mentions:    Fields:    
    2. Targeted inhibition of pathobiont virulence factor mitigates alcohol-associated liver disease. Cell Host Microbe. 2025 Jun 11; 33(6):957-972.e6. Yang Y, Duan Y, Lang S, Fondevila MF, Schöler D, Harberts A, Cabré N, Chen S, Shao Y, Vervier K, Miyamoto Y, Zhang X, Chu H, Yang L, Tan C, Eckmann L, Bosques-Padilla F, Verna EC, Abraldes JG, Brown RS, Vargas V, Altamirano J, Caballería J, Shawcross DL, Louvet A, Lucey MR, Mathurin P, Garcia-Tsao G, Bataller R, Stärkel P, Lawley TD, Schnabl B. PMID: 40441146; PMCID: PMC12162233.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    3. Role of Intestinal Microbiome in Potentiating Inflammation and Predicting Outcomes in Alcohol-Associated Cirrhosis. Gastroenterol Clin North Am. 2025 Jun; 54(2):453-467. Støy S, Schnabl B. PMID: 40348498; PMCID: PMC12066832.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Faecal proteomics links neutrophil degranulation with mortality in patients with alcohol-associated hepatitis. Gut. 2024 Dec 10; 74(1):103-115. Kreimeyer H, Gonzalez CG, Fondevila MF, Hsu CL, Hartmann P, Zhang X, Stärkel P, Bosques-Padilla F, Verna EC, Abraldes JG, Brown RS, Vargas V, Altamirano J, Caballería J, Shawcross DL, Louvet A, Lucey MR, Mathurin P, Garcia-Tsao G, Bataller R, Investigators A, Gonzalez DJ, Schnabl B. PMID: 39033024; PMCID: PMC11631684.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    5. Towards more consistent models and consensual terminology in preclinical research for steatotic liver disease. J Hepatol. 2025 Apr; 82(4):760-766. Meijnikman AS, Fondevila MF, Arrese M, Kisseleva T, Bataller R, Schnabl B. PMID: 39581500.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    6. Gut Bacteria in Alcohol-Associated Liver Disease. Clin Liver Dis. 2024 Nov; 28(4):663-679. Yang Y, Schnabl B. PMID: 39362714; PMCID: PMC11450261.
      View in: PubMed   Mentions: 4     Fields:    
    7. Endogenous ethanol production in health and disease. Nat Rev Gastroenterol Hepatol. 2024 Aug; 21(8):556-571. Meijnikman AS, Nieuwdorp M, Schnabl B. PMID: 38831008.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    8. The gut-liver axis and gut microbiota in health and liver disease. Nat Rev Microbiol. 2023 Nov; 21(11):719-733. Hsu CL, Schnabl B. PMID: 37316582; PMCID: PMC10794111.
      View in: PubMed   Mentions: 163     Fields:    Translation:Humans
    9. Intestinal clock modulates rhythmic hepatic metabolism. J Hepatol. 2023 09; 79(3):589-591. Fondevila MF, Schnabl B. PMID: 37290589.
      View in: PubMed   Mentions: 1     Fields:    
    10. Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failure. Hepatobiliary Pancreat Dis Int. 2023 Oct; 22(5):474-481. Hartmann P, Lang S, Schierwagen R, Klein S, Praktiknjo M, Trebicka J, Schnabl B. PMID: 37198098; PMCID: PMC10797562.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    11. Fungal infections and the fungal microbiome in hepatobiliary disorders. J Hepatol. 2023 04; 78(4):836-851. Hartmann P, Schnabl B. PMID: 36565724; PMCID: PMC10033447.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimals
    12. Promises of microbiome-based therapies. J Hepatol. 2022 06; 76(6):1379-1391. Bajaj JS, Ng SC, Schnabl B. PMID: 35589257; PMCID: PMC9588437.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    13. Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice. Hepatol Int. 2022 Apr; 16(2):359-370. Hartmann P, Duan Y, Miyamoto Y, Demir M, Lang S, Hasa E, Stern P, Yamashita D, Conrad M, Eckmann L, Schnabl B. PMID: 35075592; PMCID: PMC9013343.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    14. The fecal mycobiome in non-alcoholic fatty liver disease. J Hepatol. 2022 04; 76(4):788-799. Demir M, Lang S, Hartmann P, Duan Y, Martin A, Miyamoto Y, Bondareva M, Zhang X, Wang Y, Kasper P, Bang C, Roderburg C, Tacke F, Steffen HM, Goeser T, Kruglov A, Eckmann L, Stärkel P, Fouts DE, Schnabl B. PMID: 34896404; PMCID: PMC8981795.
      View in: PubMed   Mentions: 87     Fields:    Translation:HumansAnimals
    15. CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease. Nat Commun. 2021 12 09; 12(1):7172. Duan Y, Chu H, Brandl K, Jiang L, Zeng S, Meshgin N, Papachristoforou E, Argemi J, Mendes BG, Wang Y, Su H, Sun W, Llorente C, Hendrikx T, Liu X, Hosseini M, Kisseleva T, Brenner DA, Bataller R, Ramachandran P, Karin M, Fu W, Schnabl B. PMID: 34887405; PMCID: PMC8660815.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimalsCells
    16. Bacteriophages and their potential for treatment of gastrointestinal diseases. Nat Rev Gastroenterol Hepatol. 2022 02; 19(2):135-144. Duan Y, Young R, Schnabl B. PMID: 34782783; PMCID: PMC8966578.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    17. Intestinal α1-2-Fucosylation Contributes to Obesity and Steatohepatitis in Mice. Cell Mol Gastroenterol Hepatol. 2021; 12(1):293-320. Zhou R, Llorente C, Cao J, Zaramela LS, Zeng S, Gao B, Li SZ, Welch RD, Huang FQ, Qi LW, Pan C, Huang Y, Zhou P, Beussen I, Zhang Y, Bryam G, Fiehn O, Wang L, Liu EH, Yu RT, Downes M, Evans RM, Goglin K, Fouts DE, Brenner DA, Bode L, Fan X, Zengler K, Schnabl B. PMID: 33631374; PMCID: PMC8166943.
      View in: PubMed   Mentions: 18     Fields:    Translation:Animals
    18. Gut microbiome, liver immunology, and liver diseases. Cell Mol Immunol. 2021 01; 18(1):4-17. Wang R, Tang R, Li B, Ma X, Schnabl B, Tilg H. PMID: 33318628; PMCID: PMC7852541.
      View in: PubMed   Mentions: 173     Fields:    Translation:HumansAnimals
    19. The gut mycobiome: a novel player in chronic liver diseases. J Gastroenterol. 2021 Jan; 56(1):1-11. Jiang L, Stärkel P, Fan JG, Fouts DE, Bacher P, Schnabl B. PMID: 33151407; PMCID: PMC7819863.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    20. Microbiota and Fatty Liver Disease-the Known, the Unknown, and the Future. Cell Host Microbe. 2020 08 12; 28(2):233-244. Lang S, Schnabl B. PMID: 32791115; PMCID: PMC7467841.
      View in: PubMed   Mentions: 116     Fields:    Translation:HumansAnimals
    21. Transcriptomic Profiling Identifies Novel Hepatic and Intestinal Genes Following Chronic Plus Binge Ethanol Feeding in Mice. Dig Dis Sci. 2020 12; 65(12):3592-3604. Jiang L, Chu H, Gao B, Lang S, Wang Y, Duan Y, Schnabl B. PMID: 32671585; PMCID: PMC7669632.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    22. Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease. Gastroenterology. 2020 11; 159(5):1839-1852. Lang S, Demir M, Martin A, Jiang L, Zhang X, Duan Y, Gao B, Wisplinghoff H, Kasper P, Roderburg C, Tacke F, Steffen HM, Goeser T, Abraldes JG, Tu XM, Loomba R, Stärkel P, Pride D, Fouts DE, Schnabl B. PMID: 32652145; PMCID: PMC8404510.
      View in: PubMed   Mentions: 102     Fields:    Translation:Humans
    23. The selective PPAR-delta agonist seladelpar reduces ethanol-induced liver disease by restoring gut barrier function and bile acid homeostasis in mice. Transl Res. 2021 01; 227:1-14. Chu H, Jiang L, Gao B, Gautam N, Alamoudi JA, Lang S, Wang Y, Duan Y, Alnouti Y, Cable EE, Schnabl B. PMID: 32553670; PMCID: PMC7719076.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    24. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature. 2019 11; 575(7783):505-511. Duan Y, Llorente C, Lang S, Brandl K, Chu H, Jiang L, White RC, Clarke TH, Nguyen K, Torralba M, Shao Y, Liu J, Hernandez-Morales A, Lessor L, Rahman IR, Miyamoto Y, Ly M, Gao B, Sun W, Kiesel R, Hutmacher F, Lee S, Ventura-Cots M, Bosques-Padilla F, Verna EC, Abraldes JG, Brown RS, Vargas V, Altamirano J, Caballería J, Shawcross DL, Ho SB, Louvet A, Lucey MR, Mathurin P, Garcia-Tsao G, Bataller R, Tu XM, Eckmann L, van der Donk WA, Young R, Lawley TD, Stärkel P, Pride D, Fouts DE, Schnabl B. PMID: 31723265; PMCID: PMC6872939.
      View in: PubMed   Mentions: 410     Fields:    Translation:HumansAnimalsCells
    25. The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease. J Hepatol. 2020 03; 72(3):391-400. Chu H, Duan Y, Lang S, Jiang L, Wang Y, Llorente C, Liu J, Mogavero S, Bosques-Padilla F, Abraldes JG, Vargas V, Tu XM, Yang L, Hou X, Hube B, Stärkel P, Schnabl B. PMID: 31606552; PMCID: PMC7031049.
      View in: PubMed   Mentions: 118     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    26. YIPF6 controls sorting of FGF21 into COPII vesicles and promotes obesity. Proc Natl Acad Sci U S A. 2019 07 23; 116(30):15184-15193. Wang L, Mazagova M, Pan C, Yang S, Brandl K, Liu J, Reilly SM, Wang Y, Miao Z, Loomba R, Lu N, Guo Q, Liu J, Yu RT, Downes M, Evans RM, Brenner DA, Saltiel AR, Beutler B, Schnabl B. PMID: 31289229; PMCID: PMC6660779.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    27. Serum and Fecal Oxylipins in Patients with Alcohol-Related Liver Disease. Dig Dis Sci. 2019 07; 64(7):1878-1892. Gao B, Lang S, Duan Y, Wang Y, Shawcross DL, Louvet A, Mathurin P, Ho SB, Stärkel P, Schnabl B. PMID: 31076986; PMCID: PMC6588282.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    28. Role of the intestinal microbiome in liver fibrosis development and new treatment strategies. Transl Res. 2019 07; 209:22-38. Zhou R, Fan X, Schnabl B. PMID: 30853445.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimals
    29. Microbiome as a therapeutic target in alcohol-related liver disease. J Hepatol. 2019 02; 70(2):260-272. Sarin SK, Pande A, Schnabl B. PMID: 30658727.
      View in: PubMed   Mentions: 115     Fields:    Translation:HumansAnimals
    30. Antimicrobial proteins: intestinal guards to protect against liver disease. J Gastroenterol. 2019 Mar; 54(3):209-217. Hendrikx T, Schnabl B. PMID: 30392013; PMCID: PMC6391196.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    31. Reply to: "Finding fibroblast growth factor 19 during cholestasis: Does x mark the spot? J Hepatol. 2018 12; 69(6):1400-1401. Brandl K, Hartmann P, Jih LJ, Pizzo DP, Schnabl B. PMID: 30301625.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis. J Hepatol. 2018 08; 69(2):396-405. Brandl K, Hartmann P, Jih LJ, Pizzo DP, Argemi J, Ventura-Cots M, Coulter S, Liddle C, Ling L, Rossi SJ, DePaoli AM, Loomba R, Mehal WZ, Fouts DE, Lucey MR, Bosques-Padilla F, Mathurin P, Louvet A, Garcia-Tsao G, Verna EC, Abraldes JG, Brown RS, Vargas V, Altamirano J, Caballería J, Shawcross D, Stärkel P, Ho SB, Bataller R, Schnabl B. PMID: 29654817; PMCID: PMC6054564.
      View in: PubMed   Mentions: 107     Fields:    Translation:HumansCells
    33. Publisher Correction: Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus. Nat Commun. 2017 12 12; 8(1):2137. Llorente C, Jepsen P, Inamine T, Wang L, Bluemel S, Wang HJ, Loomba R, Bajaj JS, Schubert ML, Sikaroodi M, Gillevet PM, Xu J, Kisseleva T, Ho SB, DePew J, Du X, Sørensen HT, Vilstrup H, Nelson KE, Brenner DA, Fouts DE, Schnabl B. PMID: 29233961; PMCID: PMC5727102.
      View in: PubMed   Mentions: 9     Fields:    
    34. Immunoglobulin A and liver diseases. J Gastroenterol. 2018 Jun; 53(6):691-700. Inamine T, Schnabl B. PMID: 29075899; PMCID: PMC5971039.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    35. Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus. Nat Commun. 2017 10 16; 8(1):837. Llorente C, Jepsen P, Inamine T, Wang L, Bluemel S, Wang HJ, Loomba R, Bajaj JS, Schubert ML, Sikaroodi M, Gillevet PM, Xu J, Kisseleva T, Ho SB, DePew J, Du X, Sørensen HT, Vilstrup H, Nelson KE, Brenner DA, Fouts DE, Schnabl B. PMID: 29038503; PMCID: PMC5643518.
      View in: PubMed   Mentions: 114     Fields:    Translation:HumansAnimalsCells
    36. Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota. Am J Physiol Gastrointest Liver Physiol. 2016 12 01; 311(6):G1018-G1036. Bluemel S, Williams B, Knight R, Schnabl B. PMID: 27686615; PMCID: PMC5206291.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansAnimals
    37. Fast-Track Clearance of Bacteria from the Liver. Cell Host Microbe. 2016 07 13; 20(1):1-2. Llorente C, Schnabl B. PMID: 27414492.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    38. Editors' Introduction to the NAFLD and NASH Special Issue. Dig Dis Sci. 2016 May; 61(5):1211-3. Fuchs M, Schnabl B. PMID: 27068170.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    39. Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation. Cell Host Microbe. 2016 Feb 10; 19(2):227-39. Wang L, Fouts DE, Stärkel P, Hartmann P, Chen P, Llorente C, DePew J, Moncera K, Ho SB, Brenner DA, Hooper LV, Schnabl B. PMID: 26867181; PMCID: PMC4786170.
      View in: PubMed   Mentions: 205     Fields:    Translation:HumansAnimalsCells
    40. Deficiency of intestinal mucin-2 protects mice from diet-induced fatty liver disease and obesity. Am J Physiol Gastrointest Liver Physiol. 2016 Mar 01; 310(5):G310-22. Hartmann P, Seebauer CT, Mazagova M, Horvath A, Wang L, Llorente C, Varki NM, Brandl K, Ho SB, Schnabl B. PMID: 26702135; PMCID: PMC4773827.
      View in: PubMed   Mentions: 31     Fields:    Translation:Animals
    41. Methods to determine intestinal permeability and bacterial translocation during liver disease. J Immunol Methods. 2015 Jun; 421:44-53. Wang L, Llorente C, Hartmann P, Yang AM, Chen P, Schnabl B. PMID: 25595554; PMCID: PMC4451427.
      View in: PubMed   Mentions: 128     Fields:    Translation:HumansAnimalsCells
    42. Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice. FASEB J. 2015 Mar; 29(3):1043-55. Mazagova M, Wang L, Anfora AT, Wissmueller M, Lesley SA, Miyamoto Y, Eckmann L, Dhungana S, Pathmasiri W, Sumner S, Westwater C, Brenner DA, Schnabl B. PMID: 25466902; PMCID: PMC4422368.
      View in: PubMed   Mentions: 105     Fields:    Translation:HumansAnimalsCells
    43. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. Gastroenterology. 2015 Jan; 148(1):203-214.e16. Chen P, Torralba M, Tan J, Embree M, Zengler K, Stärkel P, van Pijkeren JP, DePew J, Loomba R, Ho SB, Bajaj JS, Mutlu EA, Keshavarzian A, Tsukamoto H, Nelson KE, Fouts DE, Schnabl B. PMID: 25239591; PMCID: PMC4274236.
      View in: PubMed   Mentions: 173     Fields:    Translation:AnimalsCells
    44. Nod2 deficiency protects mice from cholestatic liver disease by increasing renal excretion of bile acids. J Hepatol. 2014 Jun; 60(6):1259-67. Wang L, Hartmann P, Haimerl M, Bathena SP, Sjöwall C, Almer S, Alnouti Y, Hofmann AF, Schnabl B. PMID: 24560660; PMCID: PMC4028388.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    45. Interactions between the intestinal microbiome and liver diseases. Gastroenterology. 2014 May; 146(6):1513-24. Schnabl B, Brenner DA. PMID: 24440671; PMCID: PMC3996054.
      View in: PubMed   Mentions: 477     Fields:    Translation:HumansAnimalsCells
    46. Linking intestinal homeostasis and liver disease. Curr Opin Gastroenterol. 2013 May; 29(3):264-70. Schnabl B. PMID: 23493073; PMCID: PMC4077188.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    47. Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in mice. Gastroenterology. 2012 Nov; 143(5):1330-1340.e1. Hartmann P, Haimerl M, Mazagova M, Brenner DA, Schnabl B. PMID: 22841787; PMCID: PMC3482543.
      View in: PubMed   Mentions: 73     Fields:    Translation:AnimalsCells
    48. Fibroblast growth factor inducible 14 as potential target in patients with alcoholic hepatitis. Gut. 2013 Mar; 62(3):335-6. Schnabl B, Brenner DA. PMID: 22717452; PMCID: PMC4077319.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    49. A TLR4/MD2 fusion protein inhibits LPS-induced pro-inflammatory signaling in hepatic stellate cells. Biochem Biophys Res Commun. 2008 Oct 17; 375(2):210-4. Schnabl B, Brandl K, Fink M, Gross P, Taura K, Gäbele E, Hellerbrand C, Falk W. PMID: 18694726.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    Bernd's Networks
    Concepts (200)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (25)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-16-gff1bd585 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California